Allergy Therapeutics PLC - ESG Rating & Company Profile powered by AI
Jump to the bottom of this webpage for potential risks for Allergy Therapeutics PLC based on industry, geography and marketcap. The page includes a Q&A table on Allergy Therapeutics PLC. Other companies in the rating industry group for Allergy Therapeutics PLC are shown.
Allergy Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.3; made up of an environmental score of 5.3, social score of 1.6 and governance score of 6.0.
4.3
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
910 | Vaxcyte Inc | 4.4 | High |
910 | Yield10 Bioscience Inc | 4.4 | High |
951 | Allergy Therapeutics PLC | 4.3 | High |
951 | Cerecor Inc | 4.3 | High |
951 | Athersys Inc | 4.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Allergy Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Does Allergy Therapeutics PLC disclose current and historical energy intensity?
Does Allergy Therapeutics PLC report the average age of the workforce?
Does Allergy Therapeutics PLC reference operational or capital allocation in relation to climate change?
Does Allergy Therapeutics PLC disclose its ethnicity pay gap?
Does Allergy Therapeutics PLC disclose cybersecurity risks?
Does Allergy Therapeutics PLC offer flexible work?
Does Allergy Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Allergy Therapeutics PLC disclose the number of employees in R&D functions?
Does Allergy Therapeutics PLC conduct supply chain audits?
Does Allergy Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Allergy Therapeutics PLC conduct 360 degree staff reviews?
Does Allergy Therapeutics PLC disclose the individual responsible for D&I?
Does Allergy Therapeutics PLC disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Allergy Therapeutics PLC disclose current and / or historical scope 2 emissions?
Does Allergy Therapeutics PLC disclose water use targets?
Does Allergy Therapeutics PLC have careers partnerships with academic institutions?
Did Allergy Therapeutics PLC have a product recall in the last two years?
Does Allergy Therapeutics PLC disclose incidents of discrimination?
Does Allergy Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Has Allergy Therapeutics PLC issued a profit warning in the past 24 months?
Does Allergy Therapeutics PLC disclose parental leave metrics?
Does Allergy Therapeutics PLC disclose climate scenario or pathway analysis?
Does Allergy Therapeutics PLC disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Allergy Therapeutics PLC disclose the pay ratio of women to men?
Does Allergy Therapeutics PLC support suppliers with sustainability related research and development?
Does Allergy Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Allergy Therapeutics PLC reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Allergy Therapeutics PLC involved in embryonic stem cell research?
Does Allergy Therapeutics PLC disclose GHG and Air Emissions intensity?
Does Allergy Therapeutics PLC disclose its waste policy?
Does Allergy Therapeutics PLC report according to TCFD requirements?
Does Allergy Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Allergy Therapeutics PLC disclose energy use targets?
Does Allergy Therapeutics PLC disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Allergy Therapeutics PLC have a policy relating to cyber security?
Have a different question?
Potential Risks for Allergy Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.